Mega Matrix Inc. Announced Eight New English Short Dramas on FlexTV (March 10-14): Exploring Family, Workplace, and Life's Many Facets

SINGAPORE,March 19,2025-- From March 10 to March 14,2025,FlexTV,the global leader in short dramas under Mega Matrix Inc. (NYSE American: MPU),is launching eight English-language short dramas. Ranging

03-20

TENCENT ANNOUNCES 2024 ANNUAL AND FOURTH QUARTER RESULTS

Achieved High Quality Revenue Growth with Sustained Operating Leverage More Than Doubled Share Repurchaseto Approximately HKD112bn

03-20

Jacobio Pharma Announces 2024 Annual Results

BEIJING,SHANGHAI and BOSTON,March 19,2025-- Jacobio Pharma (1167.HK) released its 2024 annual results,with revenue of RMB160million,R&D expense of RMB330 million. Major operating and financing act

03-20

Sisram Medical Announces 2024 Annual Results

New product launches drive double-digit growth in key markets and deliver market outperformance amid economic challenges

03-20

Terumo Neuro Celebrates 15 Years of the WEB™ Device: A Game-Changing Innovation in Aneurysm Treatment

More than 25,000 Devices Implanted Worldwide from 2010-20251 ALISO VIEJO,Calif.,March 19,2025-- Terumo Neuro,a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corpor

03-20

Goldman Sachs Maintains 'Buy' Rating for Waterdrop with Price Target of US$1.80

BEIJING,March 19,2025-- Following the release ofWaterdrop Inc.\'s (WDH) fourth-quarter and full-year 2024 financial results,Goldman Sachs\' latest research report maintains a "Buy" rating fo

03-20

GCF Global Research Amplifies Movie-Goers' Voices: They Want More

Nothing Stands in the Way of a Cinema Visit When the Right Movie is Playing SYDNEY,March 20,2025-- The Global Cinema Federation (GCF),representing global cinema exhibition,is excited to announce the r

03-20

Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T‑Cell Therapy Development

CRANBURY,N.J.,March 19,2025--Porton Advanced,a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs),is pleased to announce its

03-20

HiRO and Hallym University Sacred Heart Hospital Sign Strategic MOU to Advance Drug Development

SEOUL,South Korea,March 20,2025-- Harvest Integrated Research Organization (HiRO),a boutique global CRO,is pleased to announce the signing of a Memorandum of Understanding (MOU) with Hallym Universit

03-20

Vixtel Launches New AI O&M Solution to Accelerate High-Level Intelligent Autonomous Network Transformation

HONG KONG,March 20,2025-- Vixtel Tech (an indirectwholly-owned subsidiary of IBDT,HKEX stock code: 1782) announced today the comprehensive AI upgrade of its product portfolio,fully powered by its cutt

03-20